Related Experiment Video
Updated: Jun 13, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Retrospective analysis of community pharmacists' recommendations in the North Carolina Medicaid medication therapy
Natasha Matheny Michaels1, Gretchen F Jenkins, Debra L Pruss
1Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. tmichaels@kerrhealth.com
Objectives:
To determine the economic impact of cost-saving alternatives on prescription drug costs for the North Carolina Medicaid medication therapy management (MTM) program and to assess the acceptance of recommendations made by pharmacists to prescribers and the implementation of accepted recommendations.
Design:
Retrospective analysis.
Setting:
92 Kerr Drug pharmacies in North Carolina from August 1, 2006, to July 31, 2007.
Participants:
88 North Carolina Medicaid beneficiaries who received at least 12 prescriptions each month and who completed four quarterly medication reviews by a Kerr Drug pharmacist.
Intervention:
Assessed recommendations made by Kerr Drug pharmacists.
Main Outcome Measures:
Rate of acceptance of pharmacist recommendations and overall economic impact of changing from brand-name medications to cost-saving alternatives.
Results:
Acceptance rate of pharmacist recommendations ranged from 42% to 60%. The rate at which the pharmacists' accepted recommendations were implemented at Kerr Drug pharmacy ranged from 62% to 86% across the four quarterly reviews. Overall economic impact resulted in an average cost savings of $107 per beneficiary to North Carolina Medicaid per year. Quarterly economic impact results revealed that the highest impact occurred during the first quarterly review at $63 per beneficiary.
Conclusion:
Prescriber acceptance and pharmacy implementation of cost-savings alternatives provided an annual average cost savings of $9,444 to North Carolina Medicaid. After pharmacist reimbursement, this savings totaled $2,724.
Related Concept Videos
Drug Dosing: Geriatric Patients
Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring: Affecting Factors
Analysis of Population Pharmacokinetic Data
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...